Malathion gel 0.5%

DRUG3 trials

Sponsors

Sun Pharmaceutical Industries, Inc.

Conditions

Pediculosis

Phase 1

Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice

CompletedNCT00927407

Sun Pharmaceutical Industries, Inc.Pediculosis

Start: 2009-07-31End: 2009-08-31Updated: 2013-12-24

Phase 3

Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

CompletedNCT00927472

Sun Pharmaceutical Industries, Inc.Pediculosis

Start: 2009-08-31End: 2010-06-30Updated: 2014-08-04

Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head Lice

CompletedNCT00963508

Sun Pharmaceutical Industries, Inc.Pediculosis

Start: 2009-08-31End: 2010-03-31Updated: 2014-06-13